Cambridge Investment Research Advisors’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $126K | Sell |
83,675
-6,604
| -7% | -$8.42K | ﹤0.01% | 3907 |
|
|
2026
Q1 | $103K | Buy |
90,279
+558
| +0.6% | +$687 | ﹤0.01% | 3790 |
|
|
2025
Q4 | $113K | Sell |
89,721
-6,790
| -7% | -$9.45K | ﹤0.01% | 3691 |
|
|
2025
Q3 | $150K | Sell |
96,511
-6,600
| -6% | -$9.06K | ﹤0.01% | 3547 |
|
|
2025
Q2 | $136K | Buy |
103,111
+1
| +0% | +$1 | ﹤0.01% | 3434 |
|
|
2025
Q1 | $171K | Hold |
103,110
| – | – | ﹤0.01% | 3244 |
|
|
2024
Q4 | $152K | Sell |
103,110
-451
| -0.4% | -$689 | ﹤0.01% | 3250 |
|
|
2024
Q3 | $154K | Sell |
103,561
-1,039
| -1% | -$1.54K | ﹤0.01% | 3204 |
|
|
2024
Q2 | $131K | Sell |
104,600
-460
| -0.4% | -$596 | ﹤0.01% | 3120 |
|
|
2024
Q1 | $126K | Sell |
105,060
-11,179
| -10% | -$11.2K | ﹤0.01% | 3119 |
|
|
2023
Q4 | $176K | Buy |
116,239
+290
| +0.3% | +$419 | ﹤0.01% | 2938 |
|
|
2023
Q3 | $186K | Sell |
115,949
-17,376
| -13% | -$31.6K | ﹤0.01% | 2840 |
|
|
2023
Q2 | $289K | Buy |
133,325
+1,351
| +1% | +$2.11K | ﹤0.01% | 2560 |
|
|
2023
Q1 | $193K | Sell |
131,974
-3,065
| -2% | -$3.94K | ﹤0.01% | 2841 |
|
|
2022
Q4 | $169K | Sell |
135,039
-75,277
| -36% | -$119K | ﹤0.01% | 2806 |
|
|
2022
Q3 | $397K | Sell |
210,316
-51,125
| -20% | -$121K | ﹤0.01% | 2127 |
|
|
2022
Q2 | $661K | Sell |
261,441
-1,400
| -0.5% | -$4.08K | ﹤0.01% | 1749 |
|
|
2022
Q1 | $904K | Sell |
262,841
-5,148
| -2% | -$18.2K | ﹤0.01% | 1650 |
|
|
2021
Q4 | $1.29M | Sell |
267,989
-19,085
| -7% | -$77.2K | 0.01% | 1417 |
|
|
2021
Q3 | $1.05M | Sell |
287,074
-6,867
| -2% | -$25.6K | 0.01% | 1478 |
|
|
2021
Q2 | $1.19M | Sell |
293,941
-9,781
| -3% | -$38.4K | 0.01% | 1412 |
|
|
2021
Q1 | $1.3M | Sell |
303,722
-4,199
| -1% | -$20.1K | 0.01% | 1262 |
|
|
2020
Q4 | $1.22M | Sell |
307,921
-60,357
| -16% | -$252K | 0.01% | 1185 |
|
|
2020
Q3 | $1.36M | Buy |
368,278
+19,362
| +6% | +$81.7K | 0.01% | 1009 |
|
|
2020
Q2 | $1.19M | Sell |
348,916
-27,700
| -7% | -$62K | 0.01% | 1022 |
|
|
2020
Q1 | $505K | Sell |
376,616
-8,476
| -2% | -$13.3K | ﹤0.01% | 1362 |
|
|
2019
Q4 | $566K | Sell |
385,092
-28,736
| -7% | -$48.1K | ﹤0.01% | 1498 |
|
|
2019
Q3 | $865K | Sell |
413,828
-5,714
| -1% | -$11.7K | 0.01% | 1152 |
|
|
2019
Q2 | $1.02M | Sell |
419,542
-4,125
| -1% | -$9K | 0.01% | 1015 |
|
|
2019
Q1 | $1.11M | Buy |
423,667
+81,408
| +24% | +$247K | 0.01% | 983 |
|
|
2018
Q4 | $1.03M | Sell |
342,259
-44,343
| -11% | -$150K | 0.01% | 920 |
|
|
2018
Q3 | $1.34M | Sell |
386,602
-32,442
| -8% | -$172K | 0.01% | 862 |
|
|
2018
Q2 | $1.97M | Sell |
419,044
-29,225
| -7% | -$111K | 0.02% | 654 |
|
|
2018
Q1 | $1.42M | Sell |
448,269
-40,959
| -8% | -$165K | 0.02% | 765 |
|
|
2017
Q4 | $2.4M | Buy |
489,228
+9,785
| +2% | +$56.8K | 0.03% | 521 |
|
|
2017
Q3 | $3.29M | Sell |
479,443
-10,000
| -2% | -$63.1K | 0.04% | 377 |
|
|
2017
Q2 | $3.22M | Sell |
489,443
-14,488
| -3% | -$102K | 0.05% | 362 |
|
|
2017
Q1 | $4.03M | Buy |
503,931
+6,315
| +1% | +$53.2K | 0.07% | 268 |
|
|
2016
Q4 | $4.63M | Sell |
497,616
-30,446
| -6% | -$315K | 0.09% | 213 |
|
|
2016
Q3 | $5.59M | Sell |
528,062
-65,267
| -11% | -$650K | 0.1% | 176 |
|
|
2016
Q2 | $5.54M | Sell |
593,329
-83,606
| -12% | -$849K | 0.12% | 161 |
|
|
2016
Q1 | $7.03M | Sell |
676,935
-84,936
| -11% | -$776K | 0.16% | 121 |
|
|
2015
Q4 | $7.66M | Buy |
761,871
+306,859
| +67% | +$3.08M | 0.18% | 114 |
|
|
2015
Q3 | $3.83M | Buy |
455,012
+26,062
| +6% | +$345K | 0.11% | 187 |
|
|
2015
Q2 | $6.9M | Buy |
428,950
+28,200
| +7% | +$439K | 0.19% | 109 |
|
|
2015
Q1 | $5.68M | Buy |
400,750
+5,700
| +1% | +$74.2K | 0.16% | 131 |
|
|
2014
Q4 | $3.95M | Sell |
395,050
-10,222
| -3% | -$87.5K | 0.12% | 162 |
|
|
2014
Q3 | $3.45M | Buy |
405,272
+374,700
| +1,226% | +$3.29M | 0.1% | 191 |
|
|
2014
Q2 | $270K | Sell |
30,572
-10,400
| -25% | -$90.8K | 0.01% | 1056 |
|
|
2014
Q1 | $382K | Buy |
40,972
+26,822
| +190% | +$235K | 0.01% | 838 |
|
|
2013
Q4 | $119K | Sell |
14,150
-47,050
| -77% | -$476K | ﹤0.01% | 1163 |
|
|
2013
Q3 | $539K | Buy |
61,200
+48,750
| +392% | +$391K | 0.02% | 595 |
|
|
2013
Q2 | $88K | Buy |
+12,450
| New | +$86K | ﹤0.01% | 1062 |
|
Other funds holding OPK
RCMNY
WCM
Cambridge Investment Research Advisors's OPK Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Opko Health (OPK) stake by 7.3% in Q2 2026, selling an estimated $8.42K and leaving 83,675 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #3907.
Cambridge Investment Research Advisors first reported a position in OPK in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.66M in Q4 2015. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.
- Cambridge Investment Research Advisors held 83,675 shares of Opko Health worth $126K as of Q2 2026.
- Cambridge Investment Research Advisors sold 6,604 Opko Health shares in Q2 2026, an estimated $8.42K.
- Opko Health made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3907 holding.
- Cambridge Investment Research Advisors first reported a position in Opko Health in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's Opko Health position peaked at $7.66M in Q4 2015.
- 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.